liarozole has been researched along with Dermatitis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akira, S; Amiya, T; Fujisawa, K; Hashimoto, E; Kabashima, K; Kiyono, H; Kogure, Y; Kubo, M; Kunisawa, J; Kurashima, Y; Miyake, K; Otsuka, A; Sato, S; Sato, T; Shibata, N; Suzuki, Y | 1 |
1 other study(ies) available for liarozole and Dermatitis
Article | Year |
---|---|
The enzyme Cyp26b1 mediates inhibition of mast cell activation by fibroblasts to maintain skin-barrier homeostasis.
Topics: Adenosine Triphosphate; Animals; Cell Degranulation; Cytochrome P-450 Enzyme System; Dermatitis; Fibroblasts; Imidazoles; Immunity, Innate; Mast Cells; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Microbiota; Receptors, Purinergic P2X7; Retinoic Acid 4-Hydroxylase; Skin; Toll-Like Receptor 2; Tretinoin | 2014 |